These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 35356132)

  • 1. A Meta-Analysis of Statin Use and Risk of Hepatocellular Carcinoma.
    Wang Y; Wang W; Wang M; Shi J; Jia X; Dang S
    Can J Gastroenterol Hepatol; 2022; 2022():5389044. PubMed ID: 35356132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aspirin Use and the Risk of Hepatocellular Carcinoma: A Meta-analysis.
    Wang Y; Wang M; Liu C; Wang W; Shi J; Dang S
    J Clin Gastroenterol; 2022 Aug; 56(7):e293-e302. PubMed ID: 35316225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipophilic Statins and Risk for Hepatocellular Carcinoma and Death in Patients With Chronic Viral Hepatitis: Results From a Nationwide Swedish Population.
    Simon TG; Duberg AS; Aleman S; Hagstrom H; Nguyen LH; Khalili H; Chung RT; Ludvigsson JF
    Ann Intern Med; 2019 Sep; 171(5):318-327. PubMed ID: 31426090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Meta-analysis of the effects of statins on the risk of chronic liver disease and hepatocellular carcinoma].
    Wei J; Lvy JH; Sun XJ; Wu XR
    Zhonghua Gan Zang Bing Za Zhi; 2021 Jul; 29(7):696-701. PubMed ID: 34371542
    [No Abstract]   [Full Text] [Related]  

  • 5. Statin use and risk of hepatocellular carcinoma.
    Lai SW; Liao KF; Lai HC; Muo CH; Sung FC; Chen PC
    Eur J Epidemiol; 2013 Jun; 28(6):485-92. PubMed ID: 23681775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic review with network meta-analysis: statins and risk of hepatocellular carcinoma.
    Zhou YY; Zhu GQ; Wang Y; Zheng JN; Ruan LY; Cheng Z; Hu B; Fu SW; Zheng MH
    Oncotarget; 2016 Apr; 7(16):21753-62. PubMed ID: 26943041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statin and the risk of hepatocellular carcinoma in patients with hepatitis B virus or hepatitis C virus infection: a meta-analysis.
    Li X; Sheng L; Liu L; Hu Y; Chen Y; Lou L
    BMC Gastroenterol; 2020 Apr; 20(1):98. PubMed ID: 32272891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statins are associated with a reduced risk of hepatocellular cancer: a systematic review and meta-analysis.
    Singh S; Singh PP; Singh AG; Murad MH; Sanchez W
    Gastroenterology; 2013 Feb; 144(2):323-332. PubMed ID: 23063971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of aspirin and statin use with the risk of liver cancer in chronic hepatitis B: A nationwide population-based study.
    Choi WM; Kim HJ; Jo AJ; Choi SH; Han S; Ko MJ; Lim YS
    Liver Int; 2021 Nov; 41(11):2777-2785. PubMed ID: 34242482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of perioperative use of statins, metformin, and aspirin with recurrence after curative liver resection in patients with hepatocellular carcinoma: A propensity score matching analysis.
    Khajeh E; Aminizadeh E; Moghadam AD; Ramouz A; Klotz R; Golriz M; Merle U; Springfeld C; Chang DH; Longerich T; Büchler MW; Mehrabi A
    Cancer Med; 2023 Oct; 12(19):19548-19559. PubMed ID: 37737550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statins and the risk of hepatocellular carcinoma in patients with hepatitis B virus infection.
    Tsan YT; Lee CH; Wang JD; Chen PC
    J Clin Oncol; 2012 Feb; 30(6):623-30. PubMed ID: 22271485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statins in Hepatitis B or C Patients Is Associated With Reduced Hepatocellular Carcinoma Risk: A Systematic Review and Meta-Analysis.
    Li Z; Li Y; Li X; Zhang L; Zhao N; Du H; Zhou B; Ye Y
    Turk J Gastroenterol; 2022 Feb; 33(2):136-144. PubMed ID: 35115293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-analysis: Chemoprevention of hepatocellular carcinoma with statins, aspirin and metformin.
    Zeng RW; Yong JN; Tan DJH; Fu CE; Lim WH; Xiao J; Chan KE; Tan C; Goh XL; Chee D; Syn N; Tan EX; Muthiah MD; Ng CH; Tamaki N; Lee SW; Kim BK; Nguyen MH; Loomba R; Huang DQ
    Aliment Pharmacol Ther; 2023 Mar; 57(6):600-609. PubMed ID: 36625733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statin use is associated with the reduction in hepatocellular carcinoma recurrence after liver surgery.
    Khajeh E; Moghadam AD; Eslami P; Ali-Hasan-Al-Saegh S; Ramouz A; Shafiei S; Ghamarnejad O; Dezfouli SA; Rupp C; Springfeld C; Carvalho C; Probst P; Mousavizadeh SM; Mehrabi A
    BMC Cancer; 2022 Jan; 22(1):91. PubMed ID: 35062904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can Statin Treatment Reduce the Risk of Hepatocellular Carcinoma? A Systematic Review and Meta-Analysis.
    Chang Y; Liu Q; Zhou Z; Ding Y; Yang M; Xu W; Chen K; Zhang Q; Wang Z; Li H
    Technol Cancer Res Treat; 2020; 19():1533033820934881. PubMed ID: 32552476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statin and aspirin for chemoprevention of hepatocellular carcinoma: Time to use or wait further?
    Goh MJ; Sinn DH
    Clin Mol Hepatol; 2022 Jul; 28(3):380-395. PubMed ID: 35021597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statin use and the risk of hepatocellular carcinoma in patients at high risk: A nationwide nested case-control study.
    Kim G; Jang SY; Nam CM; Kang ES
    J Hepatol; 2018 Mar; 68(3):476-484. PubMed ID: 29107150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The benefit of statins in chronic hepatitis C patients: a systematic review and meta-analysis.
    Zheng YX; Zhou PC; Zhou RR; Fan XG
    Eur J Gastroenterol Hepatol; 2017 Jul; 29(7):759-766. PubMed ID: 28240613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between Statins Types with Incidence of Liver Cancer: An Updated Meta-analysis.
    Zhang X; Lou D; Fu R; Wu F; Zheng D; Ma X
    Curr Med Chem; 2024; 31(6):762-775. PubMed ID: 37393552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statin Use and the Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B.
    Goh MJ; Sinn DH; Kim S; Woo SY; Cho H; Kang W; Gwak GY; Paik YH; Choi MS; Lee JH; Koh KC; Paik SW
    Hepatology; 2020 Jun; 71(6):2023-2032. PubMed ID: 31556128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.